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Cinco derivados de 4-trifluorometil-2-(5-aril-3-stiril-1H-pirazol-1il)-pirimidinas e seis 5-aril-
3-estiril-1-carboxamidino-1H-pirazois previamente sintetizados foram avaliados de acordo com 
suas propriedades antioxidantes e antimicrobianas. Estas atividades foram avaliadas por ensaios 
de DPPH e HRP/luminol/H2O2 quimioluminescência e suas atividades antimicrobianas (CIM). Os 
resultados foram bons para alguns compostos da série em certas concentrações em comparação 
direta com padrões.
Five previously synthesized 4-trifluoromethyl-2-(5-aryl-3-styryl-1H-pyrazol-1yl)-pyrimidines 
and six 5-aryl-3-styryl-1-carboxamidino-1H-pyrazole derivatives were screened for their 
antioxidant proprieties. The antioxidant activities were evaluated by using the DPPH and the 
HRP/luminol/H2O2 chemiluminescence assay systems and for their antimicrobial activity (MIC). 
The results were good for those series in some concentration in comparison with the standards.
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Introduction
Pyrazole derivatives represent a class of compounds 
of great importance in heterocyclic chemistry, primarily 
due to the fact that many 1H-pyrazoles are subunits of 
pharmaceutical and agrochemical agents.1 Structurally 
novel 2-(1H-pyrazol-1-yl)-pyrimidine derivatives have 
been reported to have interesting biological activity. 
Epirazole is a nonsteroidal anti-inflammatory and analgesic 
agent therapeutically applied in Japan. In addition, many 
2-(1H-pyrazol-1-yl)-pyrimidine derivatives show potent 
inhibition of induced ulcers in rats, as well as herbicidal, 
fungicidal and cardiotonic activities.2 Moreover, the 
1,3,5-triaryl-4,5-dihydropyrazole and 5-aryl-3-styryl-4,5-
dihydropyrazole derivatives are well-known fluorescent 
compounds with high emission quantum yields and are 
widely used as optical brighteners, and as fluorescence 
probes in chemosensors.3 Also, polycyclic heterocycles 
have been reported to be antioxidant and antimicrobial 
agents.4-6
Reactive oxygen species (ROS) and free radicals 
in vivo are involved in a wide range of human diseases.7 
ROS, including superoxide anion, hydrogen peroxide, and 
hydroxyl radical are by-products of a variety of pathways 
of aerobic metabolism. They are unstable and react readily 
with a wide range of biological substrates, such as lipids, 
DNA, and proteins, resulting in cell damage.8-10 Therefore, 
antioxidants may prevent damage and death of cells. 
The use of antimicrobial drugs to treat public health is 
growing and it is possible to see an emergence of bacterial 
resistance. To maintain the efficiency of the treatment of 
disease caused by bacteria, new active compounds are 
always being searched for.11
The aim of this work is to evaluate the antioxidant and 
antimicrobial activity of a series of five 2-(4,5-dihydro-
1H-pyrazol-1-yl)pyrimidines and six 1-carboxamidino-
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1H-pyrazoles (Figure 1) that were previously synthesized.3 
These new heterocyclic systems were of interest 
principally for antioxidant properties due to the presence 
of a conjugated π-system. Thus, some of these molecules 
might be important in preventing for the treatment of 
diseases related to the imbalance between formation and 
detoxification. 
Antioxidants may be classified according to their mode 
of action as free radical scavengers, chelators of metal 
ions involved in catalyzing lipid oxidation, or oxygen 
scavengers that react with oxygen in closed systems.12 
Several different methods are available and have been 
used to assess the total antioxidant capacity of numerous 
molecules. Two commonly used antioxidant evaluation 
methods, DPPH (1,1-diphenyl-2-picrylhydrazyl) radical 
scavenging and chemiluminescence determination 
in the presence of HRP, were applied to determine 
the antioxidant capacity. The target compounds were 
compared with vitamin E and N-acetyl-L-cysteine, 
respectively, as reference compounds.
Experimental
Synthesis
 The 5-aryl-1-carboxamidino-3-styryl-4,5-dihydro-
1H-pyrazoles 1a-e were synthesized by the reactions of 
1,5-diarylpenta-1,4-dien-3-ones with aminoguanidine 
hydrochloride in the presence of triethylamine in ethanol, 
under reflux for 24 h. 
Reactions of 1-carboxamidino-4,5-dihydro-1H-
pyrazole compounds with 4-alkoxy-1,1,1-trifluoro-alk-3-
en-2-ones were carried out in refluxing ethanol (2-72 h) 
with a catalytic amount of BF3·OEt2 or Ti(O-iPr)4, affording 
the 2-(5-aryl-3-styryl-4,5-dihydro-1H-pyrazol-1-yl)-4-
(trifluoromethyl) pyrimidines 2a-e.
DPPH radical scavenging assay
The DPPH radical scavenging model is extensively 
used to evaluate antioxidant activities faster than with 
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Figure 1. Chemical structures of evaluated compounds.
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other methods. Radical scavenging activity of solutions at 
several concentrations of the compounds (1a-f and 2a-e) 
were evaluated against stable DPPH (2,2-diphenyl-2-
picrylhydrazyl hydrate) spectrophotometrically according 
to Yen and Chan,13 with some modifications. The absorbance 
decrease was measured at 517 nm (10 min) on a UV-Visible 
spectrophotometer (Spectrum Power Wave X 340, Bio-Tec 
Instruments, INC). The DPPH solution (1 × 10-3 mol L-1 
in methanol) was freshly prepared. 10 mL of this solution 
were mixed with 100 mL of solutions of final concentrations 
of 500, 250, 100, 50 and 5 mg mL-1 in a 96-well plate. 
The samples were kept in the dark for 20 min at room 
temperature and then the decay of absorption was followed. 
Vitamin E was used as a positive control. The experiment 
was carried out in triplicate. Radical scavenging activity 
was calculated as follows:
where AbsDPPH – absorption of blank sample (MeOH + 
DPPH) and Abs
sample – absorption of tested solution + 
DPPH (t = 30 min).
Chemiluminescence determination in the presence of HRP
This method is based on light emission and, for 
antioxidant determination, solutions of 1 mg mL-1 of the 
test sample in phosphate buffer 5% DMSO were mixed 
with H2O2, yielding a final concentration of 5 × 10-5 mol L-1. 
Then luminol (5-amino-2,3-dihydrophthalazine-1,4-
dione, in DMSO) was added to a final concentration of 
1.13 × 10-4 mol L-1. The 96-well plate was incubated for 
3 min at 30 °C and then HRP at a final concentration of 
0.2 IU mL-1 was added to initiate the chemiluminescence 
reaction.14 Phosphate buffer / 5% DMSO  was used as a blank 
for the maximum luminescence and N-acetyl-L-cysteine 
was used as the positive control. Chemiluminescence 
was measured for 15 min at 25 °C with a microplate 
reader (Tecan-infinite®M200). Final concentrations of 
500, 250, 100, 50 and 5 mL mL-1 of the solutions were 
analyzed and the experiment was carried out in triplicate. 
The antioxidant activity was calculated by the following 
formula:
where A
control is the area under the curve of the blank 
(phosphate buffer / 5% DMSO + H2O2 + luminol + HRP) 
during 15 min and A
sample is the area under the curve of 
the sample (sample + H2O2 + luminol + HRP) during 
15 min.
Antimicrobial testing (MIC)
 In vitro antimicrobial studies were carried out against 
eight bacterial strains (Staphylococcus aureus ATCC 
29213, Bacillus subtilis ATCC 6633, Enterococcus 
faecalis ATCC 29212, Streptococcus pneumoniae ATCC 
49619, Klebsiella pneumoniae ATCC 13883, Salmonella 
typhi ATCC 19430, Escherichia coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853), and one yeast 
strain (Candida albicans ATCC 10231). The minimal 
inhibitory concentration (MIC) was determined in 
96-well culture plates by a micro-dilution method using a 
microorganism suspension with a density of 105 CFU mL-1 
in Mueller Hinton broth (MHB) incubated for 24 h at 
35 ± 1 °C for bacteria, and Sabouraud broth (SB) incubated 
for 72 h at 35 ± 1 °C for yeast, as recommended by NCCLS 
for determination of the MIC (NCCLS M100-S15 and 
M38-A).15,16 Proper blanks were assayed simultaneously 
with samples tested in triplicate. The concentrations tested 
were 500, 250, 125, 62.5, 31.25 and 16.125 mg mL-1. The 
minimum lethal concentration (MLC) was carried out by 
inoculating the suspension of the concentrations tested 
in a Petri plate with Nitrient agar and incubated 24 h at 
35 ± 1 °C for bacteria and Sabouraud agar dextrose for 72 h 
at 35 ± 1 °C for yeast. After the incubation period, the MLC 
was determined by the absence of microorganism growth.
Results and Discussion
The DPPH antioxidant assay measures the hydrogen 
donating capacity of the molecules in the sample.13,17 When 
the free radical DPPH is reduced by the sample, its colour 
changes from violet to yellow. This absorbance decline is 
measured and the antioxidant capacity can be determined. 
On the other hand, the chemiluminescence method is based 
on the light emission produced by a chemical reaction. In 
this case, the chemiluminescence oxidation of luminol 
involves the formation of a complex between the oxidant 
(H2O2) and the HRP enzyme, oxidized HRP leading to 
luminol radical production. The native enzyme (+3) reacts 
with H2O2 and, in this way, catalyzes the luminol oxidation 
(LH-) through the enzymatic cycle. Luminol reacts with the 
HRP intermediates [complex I (+5) and II (+4)] producing 
the luminol radical (L•-), which then reacts with oxygen 
resulting in the formation of an endoperoxide (LO2-). 
This endoperoxide decomposes to a excited electronically 
3-aminophthalate dianion (AP*2-), which returns to its 
ground state with emission of light. In the presence of 
antioxidant molecules (RH), the luminol radical reacts more 
quickly with these molecules than with oxygen, preventing 
the luminol radical from oxidation to 3-aminophthalate and 
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inhibiting light emission. This light emission reduction is 
considered to be a measure of the antioxidant activity.18
The samples 2a, 2c and 2e were not totally soluble in 
the DMSO/phosphate buffer system and, because of the 
lack of stability of HRP to higher levels of DMSO, the 
concentrations tested were ten times lower (50, 25, 10 and 
5 mg mL-1) in the chemiluminescence antioxidant assay. 
The higher concentrations (100, 250 and 500 mg mL-1) 
were estimated according to each curve profile in order to 
compare the results with those obtained in the DPPH assay. 
The evaluation via more than one assay is interesting 
for comparison between possible mechanisms of action 
for antioxidant properties. Profiles of the antioxidant 
potentials of the tested compounds are shown in Figure 2 
and in Table 1. Overall, DPPH assay was fairly consistent 
with the chemiluminescence assay. Thus, the compounds in 
series 1 (1a-f) shown in Figure 2A have higher potency of 
radical scavenging with good IC50 (Table 1). However, the 
compounds of series 2 (2a-e) were inactive or showed low 
activity in both tests, not being potent enough to cause 50% 
inhibition (Figure 2B). All the samples presented a better 
sensitivity in the chemiluminescence method. This method 
is known to be more sensitive because of the high light 
emission produced by the H2O2/luminol/HRP system.19
This result might also indicate that both series of 
compounds have higher antioxidant action in a mechanism 
different of electron scavenging. For the two methods tested, 
an increase of the activity was observed with increasing 
concentration. For compounds 1a to 1f, the antioxidant 
profile appears to follow the Michaelis-Menten curve.
Considering these results, an explanation for the 
potent antioxidant activity of compounds of series 1a-f 
might be found in the possible stabilization of the radical 
that is formed after hydrogen abstraction. Figure 3 shows 
the antioxidant reaction and the hydrogens that can be 
abstracted in the molecules. For the series 2a-e, resonance 
stabilization is not possible because the molecules do not 
have chain flexibility. 
Some differences in antioxidant activity for the 
series are related to the substituents present. In this case, 
for example, when we look at 1c and 1d, the presence 
of thienyl exerts a significant influence on the radical 
Figure 2. Comparative graphs of the antioxidant activity of the compounds in: a) series 1; b) series 2.
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stability in both methods of analysis. On the other hand, 
the presence of chlorine substituents does not appear to 
affect significant the antioxidant potency in comparison 
with the other compounds of the series. Another correlation 
with substituents can be seen with 1b and 1f. These two 
molecules have the same W substituent, but 1b is more 
potent in the DPPH method, probably because 1b has six 
–OCH3 substituents in the aromatic ring in contrast with 
only two in 1f. But when we compare 1b, 1e and 1f, 
although 1e has a weak donating group in R1 and R2 in 
comparison with 1b, 1e shows stronger activity because of 
the presence of the –SH group at the W position.
The results of the chemiluminescence method for 1e, 
with good antioxidant activity (78.85%) even at the lower 
concentration (5 mg mL-1), show that the –SH group exerts 
a strong influence in this system. This activity could reflect 
the rapidity of the reaction that consumes the luminol 
radical, preventing formation of 3-aminophthalate.
The DPPH and chemiluminescence methods have been 
extensively used for antioxidant activity determination 
for pure molecules and extracts, but, when we compare 
our results by both methods, is not possible to see a clear 
correlation between them. It denotes that the molecules 
tested may act by different mechanisms, principally 
when we consider the complex system present in the 
chemiluminescence method in comparison with the simple 
redox reaction in the DPPH method.
The antibacterial and antifungal activities of the 
eleven pyrazole derivatives were evaluated. Only four 
molecules were active against some of the microorganisms 
(Table 2) The compounds showed only a weak effect 
toward C. albicans. The bacteria S. typhi, S. aureus and 
S. pneumoniae were the most susceptible strains inhibited 
between 1.95 to 15.625 mg mL-1 by 1a, 1c and 1f. This 
potent antibacterial activity is only observed for compounds 
1a, 1c and 1f and not for the other closely related molecules 
Table 1. Assay results for compounds 1a-f and 2a-e
DPPH radical scavenging assay
Compouds 5 mg mL-1 50 mg mL-1 100 mg mL-1 250 mg mL-1 500 mg mL-1 IC50/(mg mL-1) Absorbance l max/ nm
1a 14.18 (± 1.9) 19.45 (± 3.6) 24.24 (± 1.1) 77.21 (± 2.5) 89.82 (± 1.1) 172.96 0.83 319.10
1b 9.70 (± 1.3) 16.12 (± 1.3) 22.55 (± 1.8) 61.82 (± 1.5) 93.94 (± 0.6) 204.88 0.75 341.20
1c 15.27 (± 1.0) 24.12 (± 3.3) 40.55 (± 3.4) 95.15 (± 0.2) 93.45 (± 0.4) 125.99 0.47 317.70
1d 15.82 (± 0.9) 54.11 (± 1.1) 91.32 (± 1.4) 94.60 (± 0.4) 96.40 (± 2.1) 45.17 0.89 353.00
1e 12.60 (± 1.2) 23.91 (± 2.6) 47.94 (± 3.7) 93.96 (± 1.5) 94.86 (± 0.2) 106.69 0.81 343.60
1f 4.95 (± 2.5) 14.65 (± 1.8) 21.47 (± 1.8) 57.97 (± 1.8) 69.02 (± 2.4) 217.22 0.84 344.00
2a 14.43 (± 0.7) 15.31 (± 0.5) 17.20 (± 0.9) 27.55 (± 1.3) 30.03 (± 0.1) - 0.95 351.40
2b 11.31 (± 1.9) 12.01 (± 1.3) 14.49 (± 0.6) 19.55 (± 1.2) 24.38 (± 4.3) - 0.87 357.60
2c 12.97 (± 0.8) 15.16 (± 2.3) 15.01 (± 1.4) 17.78 (± 1.2) 18.22 (± 0.1) - 0.84 351.20
2d 6.71 (± 0.1) 7.24 (± 0.2) 9.54 (± 0.0) 25.91 (± 7.0) 49.12 (± 3.1) - 0.93 358.60
2e 14.87(± 1.5) 15.60(± 4.4) 17.93(± 2.4) 25.22(± 1.2) 49.27(± 0.6) - 0.90 351.20
Vit. E 12.60 (± 2.6) 88.24 (± 4.1) 94.73 (± 0.2) 95.76 (± 0.1) 95.95 (± 0.3) 27.25
Chemiluminescence determination in the presence of HRP
1a 2.82 (± 0.2) 50.97 (± 2.9) 76.63 (± 2.3) 99.34 (± 0.4) 99.95 (± 0.0) 49.09 0.83 319.10
1b 1.28 (± 0.2) 30.62 (± 1.6) 77.03 (± 1.9) 99.66 (± 0.2) 99.96 (± 0.0) 70.88 0.75 341.20
1c 1.19 (± 0.1) 56.90 (± 1.6) 78.82 (± 2.5) 98.81 (± 0.9) 99.98 (± 0.0) 32.79 0.47 317.70
1d 4.54 (± 0.7) 78.16 (± 2.0) 99.42 (± 0.3) 99.93 (± 0.0) 99.96 (± 0.0) 44.43 0.89 353.00
1e 78.84 (± 2.6) 99.92 (± 0.0) 99.96 (± 0.0) 99.89 (± 0.0) 99.99 (± 0.0) 3.17 0.81 343.60
1f 1.96 (± 0.1) 36.40 (± 1.4) 93.76 (± 0.6) 99.3 (± 0.2) 99.83 (± 0.1) 61.85 0.84 344.00
2a 1.59 (± 0.8) 6.96 (± 0.8) 17.41 (± 1.6) 21.82 (± 1.4) 28.81b - 0.95 351.40
2b 5.69 (± 0.9) 6.34b 8.29b 11.53 (± 0.7) 16.91 (± 1.4) - 0.87 357.60
2c 1.77 (± 1.7) 17.40 (± 3.1) 29.42 (± 0.8) 37.31 (± 2.4) 48.36b 105.54 0.84 351.20
2d 6.12 (± 1.1) 7.36b 11.07b 17.26 (± 1.8) 22.15 (± 0.4) - 0.93 358.60
2e 3.70 (± 0.5) 19.30 (± 1.2) 30.31 (± 0.9) 34.72 (± 2.3) 46.49b 130.28 0.90 351.20
Controla 11.98 (± 1.1) 21.62 (± 0.0) 50.55 (± 0.0) 98.76 (± 1.1) 99.89 (± 0.0) 24.72
aN-acetyl-L-cisteine; bestimated value.
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(1b, 1d and 1e), suggesting a mode of action that is structure 
specific. The presence of chlorine appears to affect the 
activity, but when the thienyl group is present, no cell 
inhibitory effect can be seen. The substituent –SH in the W 
position probably is responsible for the weak activity of 1e 
against the fungus C. albicans. We also note that only small 
substituents can affect antimicrobial potency. Comparing 
1b and 1f, when there are more –OCH3 substituents in the 
aromatic ring, the antimicrobial activity is lost. 
For the antimicrobial active compounds, we also tested 
the Minimum Lethal Concentration (MLC). As shown in 
Table 2, most of the compounds were able to kill the strains 
at concentrations not much higher than the MIC.
Conclusions
In summary, we tested two different series of 
heterocycles at several concentrations to evaluate their 
antioxidant and antimicrobial activity. Our results have 
shown that 1-carboxyamidino-1H-pyrazole derivatives 
exhibit good antioxidant properties in both tests. These 
activities are related to the concentration and type of 
substituents present in each compound and resonance 
stabilization (Figure 3) may be the determining factor. 
In the antimicrobial test, we also observed a substituent 
dependence of the activity.
Table 2. Antimicrobial potency of the active molecules 1a, 1c, 1e and 1f (concentrations are given in mg mL-1)
Microorganisms 1a 1c 1e 1f
MIC MLC MIC MLC MIC MLC MIC MLC
E. faecalis n.a. ND n.a. ND n.a. ND n.a. ND
K. pneumonae 500 500 125 ND n.a. ND 250 ND
S. typhi 15.625 ND 15.625 15.625 n.a. ND 15.625 15.625
S. aureus 1.95 3.90 3.90 7.81 n.a. ND 15.625 ND
S. pneumoniae 1.95 7.81 7.81 ND n.a. ND 15.625 ND
B. subtilis n.a. ND n.a. ND n.a. ND n.a. ND
E. coli 250 ND 250 ND n.a. ND 250 ND
P. aeruginosa 500 ND n.a. ND n.a. ND n.a. ND
C. albicans 62.5 125 500 ND 500 ND 125 250
n.a. not active. ND: not detected. Positive control: tetracycline (8 to 32 µg mL-1) for bacteria and fuconazole (0.125 to 65 µg mL-1) for yeast.
Figure 3. Antioxidant reaction and indication of the hydrogens that are probably abstracted in the reaction.
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